Advanced Accelerator Applications (AAA) - Novartis
Advanced Accelerator Applications is a radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicines including Lutathera ® ( 177 Lu-DOTATATE), a first-in-class RLT product for neuroendocrine tumors (NETs). Source (opens in a new tab)
- Headquarters
- FR